REHOVOT, Israel, Nov. 12, 2015 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that CEO Oded S. Lieberman, PhD will present at the following investor conferences:
- Jefferies Autumn 2015 Global Healthcare Conference taking place in London, from November 18 – 19, 2015. Dr. Lieberman's presentation will take place on Wednesday, November 18, at 3:20pm GMT, 10:20am ET.
- Oppenheimer 26th Annual Healthcare Conference taking place in New York from December 8 – 9, 2015. Dr. Lieberman's presentation will take place on Wednesday, December 9 at 1:35pm ET.
To access the live webcasts of these presentations, please visit ir.neuroderm.com/. Replays will be available for one month following each presentation.
NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhanced clinical efficacy through continuous, controlled administration. NeuroDerm is headquartered in the Rabin Science Park, Rehovot, Israel.
CONTACT: NeuroDerm Contact: Oded S. Lieberman, PhD MBA, CEO firstname.lastname@example.org Tel.: +972-8-946 2729 Cell: +1-617-517 6077 U.S. Investor Contact: David Carey Lazar Partners Ltd. email@example.com +212-867-1762